Cell-Free (cfDNA) Based Evaluation of KRAS Mutation Profile in Solid Tumors With Focus on G12C Variant

• S. Limaye,
• S. Rajappa,
• A. Gaya,
• R. Ajami,
• R. Vijayakumar,
• A. Vaid,
• D. Akolkar,
• D. Patil,
• V. Datta,
• R. Datar,
• M. Cristofanilli

Affiliations

S. Limaye

Sir H. N. Reliance Foundation Hospital, Mumbai, India

S. Rajappa

Basavatarakam Indo American Cancer Hospital & Research Institute, Hyderabad, India

A. Gaya

Cromwell Hospital, London, UK

R. Ajami

Royal Free Hospital, London, UK

R. Vijayakumar

BGS Gleneagles Global Hospital, Bengaluru, India

A. Vaid

Medanta - The Medicity, Gurugram, India

D. Akolkar

Datar Cancer Genetics Private Limited, Nasik, India

D. Patil

Datar Cancer Genetics Private Limited, Nasik, India

V. Datta

Datar Cancer Genetics Private Limited, Nasik, India

R. Datar

Datar Cancer Genetics Private Limited, Nasik, India

M. Cristofanilli

Weill Cornell Medicine, New York, USA